VNDA icon

Vanda Pharmaceuticals

86 hedge funds and large institutions have $393M invested in Vanda Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-13
Holders Change %
-13.13%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
20
Increased
35
Reduced
21
Closed
33
Calls
$36M
Puts
$17.1M
Net Calls
+$18.9M
Net Calls Change
-$1.46M
Name Holding Trade Value Shares
Change
Shares
Change %
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
-$734K -67,084 Closed
SCA
102
SAC Capital Advisors
Connecticut
-$730K -66,500 Closed
DCM
103
Driehaus Capital Management
Illinois
-$651K -59,486 Closed
FAM
104
Fortaleza Asset Management
Illinois
-$430K -39,275 Closed
AG
105
Algert Global
California
-$293K -26,733 Closed
SCM
106
Stevens Capital Management
Pennsylvania
-$233K -21,274 Closed
VKH
107
Virtu KCG Holdings
New York
-$214K -19,511 Closed
JG
108
Jefferies Group
New York
-$198K -18,100 Closed
LMF
109
LMR Master Fund
Cayman Islands
-$182K -16,582 Closed
DTL
110
Dynamic Technology Lab
Singapore
-$146K -13,306 Closed
Arrowstreet Capital
111
Arrowstreet Capital
Massachusetts
-$143K -13,044 Closed
GGHC
112
Gilder Gagnon Howe & Co
New York
-$130K -11,908 Closed
GCP
113
GSA Capital Partners
United Kingdom
-$112K -10,212 Closed
AAP
114
Ardsley Advisory Partners
Connecticut
-$110K -10,000 Closed
SG Americas Securities
115
SG Americas Securities
New York
-$105K -9,607 Closed
MAA
116
Managed Account Advisors
New Jersey
-$84K -7,676 Closed
TRCT
117
Tower Research Capital (TRC)
New York
-$78K -7,044 Closed
EWM
118
Edge Wealth Management
New York
-$38K -3,500 Closed
PFG
119
Piershale Financial Group
Illinois
-$1K -101 Closed